-
Dual-Action Kinase Inhibitors Accelerate p38α Dephosphorylat
2026-06-05
The reference study reveals that certain kinase inhibitors, including BIRB 796 (Doramapimod), not only block p38α MAPK activity but also promote its dephosphorylation by stabilizing specific inactive conformations. These findings introduce a dual-action paradigm with implications for designing more selective and potent inhibitors for inflammation and apoptosis research.
-
Eicosapentaenoic Acid in Cardiovascular and Immunity Researc
2026-06-05
Leverage Eicosapentaenoic Acid (EPA) as an advanced omega-3 fatty acid tool for cardiovascular disease and immunomodulatory research. This guide details robust workflows, troubleshooting tactics, and new cross-domain innovations, empowering scientists with actionable protocol parameters and comparative analysis.
-
Sodium Selenite Suppresses Cervical Cancer via ROS and Metab
2026-06-04
This study demonstrates that sodium selenite inhibits cervical cancer progression by inducing ROS-mediated suppression of glucose metabolic reprogramming through the AKT/mTOR/HIF-1α pathway. The data provide mechanistic insight into selenium's selective anticancer effects and suggest new directions for targeted therapy.
-
LMO2–LDB1 Complex Drives AML Progression and Offers Targets
2026-06-04
This study reveals that the interaction between LMO2 and LDB1 is essential for the proliferation and survival of acute myeloid leukemia (AML) cells. By dissecting the molecular mechanisms and functional impact of the LMO2/LDB1 complex, the research highlights potential therapeutic targets for future AML interventions.
-
PSMD14-CARM1 Axis Drives HCC via FERMT1: Mechanistic Insight
2026-06-03
This study uncovers how PSMD14-mediated deubiquitination stabilizes CARM1, promoting hepatocellular carcinoma (HCC) proliferation and metastasis through activation of FERMT1 transcription. The work highlights CARM1 as a key oncogenic driver in HCC and a promising therapeutic target, with implications for targeted protease inhibition in cancer research.
-
Structural Insights into Bestatin Inhibition of Leucine Amin
2026-06-03
This study elucidates the structural basis of Bestatin (Ubenimex) inhibition of leucine aminopeptidase (LAP) at atomic resolution, revealing how the inhibitor mimics catalytic intermediates and interacts with key zinc-coordinated residues. The findings advance understanding of exopeptidase regulation and inform the rational design of potent aminopeptidase inhibitors for biochemical and translational research.
-
Asiaticoside Suppresses TGF-β1-Induced MMT via Nrf2/HO-1 Pat
2026-06-02
Zhao et al. demonstrated that asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition (MMT) and oxidative stress in human peritoneal mesothelial cells by activating the Nrf2/HO-1 signaling pathway. The study provides mechanistic evidence for targeting both TGF-β/Smad and oxidative stress axes to prevent peritoneal fibrosis in dialysis-related contexts.
-
MOG (35-55) Peptide: Precision Tool for Autoimmune Encephalo
2026-06-02
MOG (35-55) is a myelin oligodendrocyte glycoprotein peptide crucial for inducing experimental autoimmune encephalomyelitis (EAE), enabling reproducible modeling of multiple sclerosis (MS). Its well-characterized mechanism and consistent performance make it a gold-standard reagent for autoimmune disease research.
-
Proximity Proteomics Enables Single-Cell Spatial Proteome Pr
2026-06-01
The referenced study introduces PSPro, a proximity labeling-based approach enabling high-resolution, cell-type-specific spatial proteome profiling within single tissue slices. By optimizing antibody-targeted biotinylation and integrating laser microdissection, the method overcomes limitations of throughput and proteome coverage, offering new insights into tissue heterogeneity.
-
Phosphatase Inhibitor Cocktail 1: Enhancing Phosphoproteomic
2026-06-01
Phosphatase Inhibitor Cocktail 1 (100X in DMSO) secures labile phosphorylation states during sample preparation, delivering reproducible, high-fidelity data for advanced signal transduction and phosphoproteomic studies. Discover how APExBIO's optimized formulation bridges bench-to-biomedical workflows and facilitates robust troubleshooting in complex protein analyses.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Precision in Translat
2026-05-31
Explore how the Annexin V-FITC/PI Apoptosis Assay Kit advances early apoptosis detection in translational liver research. This article uniquely links mechanistic cell death insights to current innovations in hepatic transplantation, setting a new standard for apoptosis assay rigor.
-
Tankyrase 1/2 Inhibitors Modulate Hippo Pathway in HCC Cells
2026-05-30
Jia et al. (2017) demonstrated that selective tankyrase 1/2 inhibitors, including G007-LK, suppress hepatocellular carcinoma (HCC) cell growth by modulating the Hippo-YAP signaling cascade. This work highlights a mechanistic convergence between Wnt/β-catenin and Hippo pathways and suggests new therapeutic strategies for tankyrase-driven cancers.
-
EZ Cap™ Cre mRNA (m1Ψ): Advanced Workflows for Gene Editing
2026-05-29
EZ Cap™ Cre mRNA (m1Ψ) redefines gene editing workflows by integrating m1Ψ modification for enhanced stability and low immunogenicity. This article details experimental setups, protocol optimization, and troubleshooting for high-efficiency Cre recombinase mRNA delivery—especially in challenging extrahepatic contexts.
-
MDL 28170 Calpain Inhibitor: Neuroprotection & Workflow Mast
2026-05-29
MDL 28170 stands apart as a highly selective, cell-permeable calpain and cathepsin B inhibitor, enabling rigorous dissection of protease-driven pathology in neurodevelopment, ischemia-reperfusion, and infection models. Harness insights from cutting-edge translational studies to refine your experimental design, maximize neuroprotection, and achieve reproducible outcomes in challenging systems.
-
Betacoronaviruses and the Integrated Stress Response in Lung
2026-05-28
This study systematically dissects how different human betacoronaviruses—including MERS-CoV, HCoV-OC43, and SARS-CoV-2—interact with the integrated stress response (ISR) and translational control in lung-derived cell lines. The findings reveal virus-specific strategies for modulating eIF2α phosphorylation and highlight new avenues for host-directed antiviral research.